Published in J Immunol Methods on April 15, 2009
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc Natl Acad Sci U S A (2010) 1.37
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res (2012) 1.08
Nanoengineering approaches to the design of artificial antigen-presenting cells. Nanomedicine (Lond) (2013) 0.88
Lipid antigens in immunity. Biol Chem (2014) 0.79
Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells. J Vis Exp (2012) 0.79
Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells. J Interferon Cytokine Res (2012) 0.78
Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential. Front Immunol (2017) 0.75
Generation of Human iNKT Cell Lines. Bio Protoc (2013) 0.75
Development of a qPCR method to rapidly assess the function of NKT cells. J Immunol Methods (2014) 0.75
Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine (2015) 0.75
Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis. J Immunol Res (2016) 0.75
Generation of Mouse iNKT Cell Lines. Bio Protoc (2013) 0.75
A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice. Expert Rev Vaccines (2016) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 13.67
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med (1994) 7.35
CD1: antigen presentation and T cell function. Annu Rev Immunol (2004) 6.89
Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature (1994) 6.13
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature (2001) 5.08
CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science (2003) 3.05
Glycolipid antigen processing for presentation by CD1d molecules. Science (2001) 3.04
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A (1998) 2.96
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature (2000) 2.87
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci U S A (2005) 2.83
Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol (2009) 2.79
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J Exp Med (2003) 2.64
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med (2002) 2.38
Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med (2003) 2.30
CD1 antigen presentation: how it works. Nat Rev Immunol (2007) 2.27
CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med (2002) 2.22
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat Med (2003) 2.21
NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol (2007) 2.19
Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol (2004) 2.09
Presentation of the same glycolipid by different CD1 molecules. J Exp Med (2002) 2.06
Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med (1999) 2.06
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol (1999) 1.96
Saposin C is required for lipid presentation by human CD1b. Nat Immunol (2004) 1.88
Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med (2005) 1.78
The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. J Immunol (2003) 1.69
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J Biol Chem (2003) 1.61
Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J (1988) 1.41
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci U S A (1993) 1.36
Conservation of a CD1 multigene family in the guinea pig. J Immunol (1999) 1.34
Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int Immunol (2003) 1.32
Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell Mol Life Sci (2006) 1.27
CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytes. J Immunol (2007) 1.20
DynaPred: a structure and sequence based method for the prediction of MHC class I binding peptide sequences and conformations. Bioinformatics (2006) 1.18
Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol (2002) 1.16
CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. J Immunol (2005) 1.15
Acidocalcisomes and a vacuolar H+-pyrophosphatase in malaria parasites. Biochem J (2000) 1.14
Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. J Biol Chem (2003) 1.08
Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J Immunol (2005) 1.08
Ascites specific inhibition of CD1d-mediated activation of natural killer T cells. Clin Cancer Res (2008) 0.96
Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules. Eur J Immunol (2008) 0.93
Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay. Anal Biochem (2001) 0.91
CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1. J Immunol (2004) 0.85
Recognition of bacterial glycosphingolipids by natural killer T cells. Nature (2005) 6.38
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med (2007) 5.65
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 3.48
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med (2011) 2.78
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J Exp Med (2003) 2.64
Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med (2002) 2.38
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A (2005) 2.13
Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J Immunol (2009) 1.81
Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc Natl Acad Sci U S A (2006) 1.74
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens. J Gastroenterol (2003) 1.54
Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina. J Cardiol (2012) 1.48
Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity. J Am Chem Soc (2006) 1.47
Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res (2008) 1.42
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc Natl Acad Sci U S A (2010) 1.37
The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity. Angew Chem Int Ed Engl (2004) 1.31
Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A (2005) 1.29
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J Immunol (2008) 1.26
Assessment of optimal condylar position with limited cone-beam computed tomography. Am J Orthod Dentofacial Orthop (2009) 1.22
Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Res (2007) 1.19
Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis. Org Lett (2004) 1.19
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide. Vaccine (2008) 1.19
Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis (2008) 1.16
Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice. J Clin Invest (2010) 1.12
Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells. Immunology (2009) 1.12
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol (2008) 1.11
High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.09
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res (2012) 1.08
Endothelin in a murine model of cerebral malaria. Exp Biol Med (Maywood) (2006) 1.06
Alpha-c-galactosylceramides: synthesis and immunology. Acc Chem Res (2006) 1.05
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine (2009) 1.05
E and Z alpha-C-galactosylceramides by Julia-Lythgoe-Kocienski chemistry: a test of the receptor-binding model for glycolipid immunostimulants. Chembiochem (2006) 1.04
Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection. Int Immunol (2007) 1.03
Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif. Vaccine (2004) 1.02
Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production. J Am Chem Soc (2008) 1.01
Relationship between masticatory function and internal structure of the mandible based on computed tomography findings. Am J Orthod Dentofacial Orthop (2005) 1.00
Gastric ulcer associated with cytomegalovirus in an immunocompetent patient: method for diagnosis. Case Rep Gastroenterol (2012) 0.99
Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun (2013) 0.99
Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J Gastroenterol Hepatol (2003) 0.98
A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. J Immunol (2007) 0.97
Reduced cerebral blood flow and N-acetyl aspartate in a murine model of cerebral malaria. Parasitol Res (2005) 0.97
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant. Clin Immunol (2010) 0.96
The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria. J Immunol (2003) 0.96
Ascites specific inhibition of CD1d-mediated activation of natural killer T cells. Clin Cancer Res (2008) 0.96
Carbohydrates and T cells: a sweet twosome. Semin Immunol (2013) 0.95
A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity. J Immunol (2010) 0.93
Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine (2011) 0.92
Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells. J Immunol (2009) 0.92
Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat Protoc (2012) 0.90
Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides. Bioorg Med Chem (2005) 0.89
Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo. J Immunol Methods (2012) 0.88
Modulation of MHC binding by lateral association of TCR and coreceptor. Biophys J (2012) 0.88
A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. PLoS One (2013) 0.87
Assessment of optimal condylar position in the coronal and axial planes with limited cone-beam computed tomography. J Prosthodont (2011) 0.87
The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites. Microbes Infect (2003) 0.87
Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis (2006) 0.87
A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity. Semin Immunol (2009) 0.86
Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis (2012) 0.85
Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J Gastroenterol (2002) 0.85
Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res (2009) 0.85
A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer. J Biomed Biotechnol (2009) 0.84
Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J (2006) 0.84
Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb (2011) 0.83
Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter (2002) 0.83
Is chronic kidney disease associated with coronary artery stenosis or calcification as assessed by multi-detector row computed tomography? Intern Med (2008) 0.83
Synthesis and antitumor activity of C-9 epimers of the tetrahydrofuran containing acetogenin 4-deoxyannoreticuin. Bioorg Med Chem (2008) 0.83
Selective photolabeling of Lck kinase in complex proteome. Bioorg Med Chem Lett (2006) 0.82
Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation. Intern Med (2013) 0.82
Synthesis, characterization, mechanism of decomposition, and antiproliferative activity of a class of PEGylated benzopolysulfanes structurally similar to the natural product varacin. J Org Chem (2010) 0.82
Acute coronary syndrome associated with essential thrombocythemia. J Cardiol (2009) 0.82
Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem Biophys Res Commun (2003) 0.81
Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model. J Clin Immunol (2010) 0.81
Immunomodulatory activity of a lupane triterpenoid ester isolated from the eastern Nigeria mistletoe, Loranthus micranthus (Linn). Asian Pac J Trop Med (2011) 0.81
JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways. Atherosclerosis (2005) 0.80
Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease. Intern Med (2009) 0.80
Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase. Atherosclerosis (2005) 0.80
Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina. Intern Med (2008) 0.80
Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease. J Atheroscler Thromb (2010) 0.79
Angiographic late lumen loss at the site of overlap of multiple Cypher™ sirolimus-eluting stents: ALSOCE study. J Cardiol (2010) 0.78
Gene expression profiling of intrinsic thermotolerance in Escherichia coli. Curr Microbiol (2006) 0.78
Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction. Intern Med (2006) 0.78
Three hydroxylated lupeol-based triterpenoid esters isolated from the Eastern Nigeria mistletoe parasitic on Kola acuminata. Nat Prod Res (2011) 0.78
A novel sesquiterpene acid and an alkaloid from leaves of the Eastern Nigeria mistletoe, Loranthus micranthus with potent immunostimulatory activity on C57BL6 mice splenocytes and CD69 molecule. Pharm Biol (2011) 0.78
Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation. BMC Immunol (2013) 0.78
Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina. Coron Artery Dis (2011) 0.77
Are metabolic factors associated with coronary artery stenosis on MDCT? Circ J (2008) 0.77
Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol (2012) 0.77
Association between cardiac function and metabolic factors including adiponectin in patients with acute myocardial infarction. J Cardiol (2008) 0.76
Peripheral blood invariant natural killer T cells of pig-tailed macaques. PLoS One (2012) 0.76
Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection. J Gastroenterol Hepatol (2003) 0.76
Homocysteine-induced oxidative stress upregulates chymase in mouse mastocytoma cells. Hypertens Res (2009) 0.75
Circumsporozoite protein as a potential target for antimalarials. Expert Rev Anti Infect Ther (2015) 0.75
Immunostimulatory lipid nanoparticles from herbal medicine. Chem Biol Drug Des (2014) 0.75
Reproducible enrichment of extracellular heat shock proteins from blood serum using monomeric avidin. Bioorg Med Chem Lett (2011) 0.75
Synthesis and anti-tumor activity of carbohydrate analogues of the tetrahydrofuran containing acetogenins. Bioorg Med Chem (2013) 0.75
Giant thrombus filling the pulmonary trunk. Intern Med (2012) 0.75
[Series: clinical study from Japan and its reflections; impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention:--from the FU-registry--(UMIN registration no. 000005679)]. Nihon Naika Gakkai Zasshi (2012) 0.75
Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography. Intern Med (2007) 0.75
Efficacy and safety of drug-eluting stents in long-term follow-up. Intern Med (2008) 0.75
Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan. J Cardiol (2008) 0.75